Correlation Between Lantheus Holdings and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Lantheus Holdings and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lantheus Holdings and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lantheus Holdings and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Lantheus Holdings and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lantheus Holdings with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lantheus Holdings and Sunshine Biopharma.

Diversification Opportunities for Lantheus Holdings and Sunshine Biopharma

-0.54

Correlation Coefficient

Lantheus Holdings  Sunshine Biopharma

Excellent diversification

The 3 months correlation between Lantheus and Sunshine is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Lantheus Holdings and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Lantheus Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lantheus Holdings are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Lantheus Holdings i.e., Lantheus Holdings and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Lantheus Holdings and Sunshine Biopharma

Given the investment horizon of 90 days Lantheus Holdings is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Lantheus Holdings is 6.84 times less risky than Sunshine Biopharma. The stock trades about -0.04 of its potential returns per unit of risk. The Sunshine Biopharma Warrant is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Sunshine Biopharma Warrant on September 12, 2024 and sell it today you would earn a total of  11.80  from holding Sunshine Biopharma Warrant or generate 107.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	89.06%
Values	Daily Returns

Lantheus Holdings  vs.  Sunshine Biopharma Warrant

Lantheus Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lantheus Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Sunshine Biopharma

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lantheus Holdings and Sunshine Biopharma

The main advantage of trading using opposite Lantheus Holdings and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lantheus Holdings position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Lantheus Holdings and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.